Advertisement
Browse Subject Areas
?

Click through the PLOS taxonomy to find articles in your field.

For more information about PLOS Subject Areas, click here.

  • Loading metrics

Open Access

Correction

Correction: Oxytocin in Uniject Disposable Auto-Disable Injection System versus Standard Use for the Prevention of Postpartum Hemorrhage in Latin America and the Caribbean: A Cost-Effectiveness Analysis

  • Andrés Pichon-Riviere,
  • Demián Glujovsky,
  • Osvaldo Ulises Garay,
  • Federico Augustovski,
  • Agustin Ciapponi,
  • Magdalena Serpa,
  • Fernando Althabe

In Table 2, the values in the second column are incorrect. All values should be represented in the thousands. Please see the corrected Table 2 here.

thumbnail
Download:
Table 2. Country-specific parameters: Base case values, ranges used in sensitivity analysis and source of data.

https://doi.org/10.1371/journal.pone.0133344.t001

There are errors in Fig 2 where “threshold” is misspelled three times. Please view Fig 2 here.

thumbnail
Download:
Fig 2. Sensitivity analysis: scatter plot of simulated differences in costs and QALYs between Uniject and current practice of oxytocin in ampoules each 1,000 deliveries in Cuba, Brazil, Chile, Colombia and Panama (origin represents current practice).

https://doi.org/10.1371/journal.pone.0133344.g001

Notes: GDPpc: Gross Domestic Product per capita; QALYs: Quality Adjusted Life Years. Notes: These five countries were selected to reflect the range of results obtained in the incremental cost-effectiveness ratios (ICERs) in the 30 Latin American and Caribbean countries analysed (percentiles 10%-Cuba, 25%-Colombia, 50%-Brazil, 75%-Panama and 90%-Chile). Each point represents 1 of the 1000 simulated ICERs in the probabilistic sensitivity analysis for each country. Probabilities of being Cost-Saving, or Cost-Effective at 1 and 3 GDPpc for all countries can be seen in Table 2.

Reference

  1. 1. Pichon-Riviere A, Glujovsky D, Garay OU, Augustovski F, Ciapponi A, Serpa M, et al. (2015) Oxytocin in Uniject Disposable Auto-Disable Injection System versus Standard Use for the Prevention of Postpartum Hemorrhage in Latin America and the Caribbean: A Cost-Effectiveness Analysis. PLoS ONE 10(6): e0129044. pmid:26057930

Citation: Pichon-Riviere A, Glujovsky D, Garay OU, Augustovski F, Ciapponi A, Serpa M, et al. (2015) Correction: Oxytocin in Uniject Disposable Auto-Disable Injection System versus Standard Use for the Prevention of Postpartum Hemorrhage in Latin America and the Caribbean: A Cost-Effectiveness Analysis. PLoS ONE 10(7): e0133344. https://doi.org/10.1371/journal.pone.0133344

Published: July 15, 2015

Copyright: © 2015 Pichon-Riviere et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited